What happened
AprilBio disclosed convertible bonds to raise US$100M, about 35.0% of its market value.
For context, this raise equals about 35.0% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$100M |
| vs. market value | 35.0% |
| Filed | 2026-06-25, Material event report (rights offering) |
| Source | DART rcept 20260625000001 → open original filing |
Source: DART. Information only, not investment advice.